Cargando…
Reply to a fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era
Autores principales: | Leng, Wen-Xiu, Yang, Yue-Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463111/ https://www.ncbi.nlm.nih.gov/pubmed/34571113 http://dx.doi.org/10.1016/j.ijcard.2021.09.043 |
Ejemplares similares
-
A fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era
por: Jamal, Javeria, et al.
Publicado: (2021) -
Reply to letter to the editor: Revascularization strategy in patients with acute ST-elevation myocardial infarction amid COVID-19 pandemic
por: Li, Yi-Heng, et al.
Publicado: (2021) -
Impact of the shift to a fibrinolysis-first strategy on care and outcomes of patients with ST-segment–elevation myocardial infarction during the COVID-19 pandemic—The experience from the largest cardiovascular-specific centre in China
por: Leng, Wen-Xiu, et al.
Publicado: (2021) -
Revascularization strategy in patients with acute ST-elevation myocardial infarction amid COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2021) -
Evaluation of renal dysfunction after ST-elevation myocardial infarction
por: İşcan, Şahin, et al.
Publicado: (2018)